Grantham, Mayo, Van Otterloo & Co (GMO)
IBEX icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s IBEX IBEX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio IBEX Stock Details IBEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Sell
6,882
-3,835
-36% -$114K ﹤0.01% 642
2026
Q1 		$287K Sell
10,717
-821
-7% -$26.6K ﹤0.01% 592
2025
Q4 		$441K Sell
11,538
-558
-5% -$20.6K ﹤0.01% 588
2025
Q3 		$490K Sell
12,096
-3,900
-24% -$124K ﹤0.01% 527
2025
Q2 		$465K Buy
15,996
+1,438
+10% +$38.5K ﹤0.01% 542
2025
Q1 		$354K Buy
+14,558
New +$349K ﹤0.01% 566

Other funds holding IBEX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s IBEX Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its IBEX (IBEX) stake by 36% in Q2 2026, selling an estimated $114K and leaving 6,882 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IBEX in Q1 2025 and has held it in 6 quarters since. The position peaked at $490K in Q3 2025. 153 funds tracked by Wall St. Rank hold IBEX as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 6,882 shares of IBEX worth $209K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,835 IBEX shares in Q2 2026, an estimated $114K.
  • IBEX made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #642 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IBEX in Q1 2025 and has held it in 6 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s IBEX position peaked at $490K in Q3 2025.
  • 153 funds tracked by Wall St. Rank held IBEX as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.